Drug or treatment

Infliximab clinical trials

• 24Clinical trials
• 11Countries

Newest trials

All recruiting trials (24)

• Single-dose MT-201 with Infliximab in healthy adults

  This early phase study tests a single dose of MT-201 given with infliximab in healthy adults to see if it is safe and how the body handles it.

  Recruiting Phase 1 Mirador Therapeutics, Inc. · San Diego, California · NCT07776782

• Infliximab plus prednisone vs prednisone alone for ICI-associated AKI

  This study tests whether adding infliximab to prednisone helps adults with kidney injury caused by cancer immunotherapy recover kidney function faster than standard prednisone alone.

  Recruiting at 2 sites Phase 4 Massachusetts General Hospital · Boston, Massachusetts and 2 other locations · NCT07683975

• Infliximab to Help Prevent CRS During Teclistamab or Talquetamab Therapy in Relapsed/Refractory Myeloma

  This phase 2 trial tests whether infliximab can prevent cytokine release syndrome in patients with relapsed or refractory multiple myeloma who are being treated with teclistamab or talquetamab.

  Recruiting Phase 2 Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT07657312

• Upadacitinib versus infliximab for second-line treatment of acute severe ulcerative colitis

  This trial will see if upadacitinib or infliximab works better to induce remission in adults with acute severe ulcerative colitis who need second-line therapy.

  Recruiting at 4 sites Phase 4 Xijing Hospital of Digestive Diseases · Ankang, Shaanxi and 3 other locations · NCT07550673

• Infliximab level monitoring in children with inflammatory bowel disease

  This project will test whether measuring infliximab levels in saliva and leftover blood during the first infusions helps monitor and personalize treatment for children and teens (ages 3–18) with Crohn's disease or ulcerative colitis.

  Recruiting Meyer Children's Hospital IRCCS · Florence, Italy · NCT07470502

• Dexamethasone before infliximab for moderate-to-severe Crohn's disease and ulcerative colitis

  This project will test whether giving an IV dose of dexamethasone before infliximab infusions prevents allergic reactions in people aged 14–80 with moderate-to-severe Crohn's disease or ulcerative colitis.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07385131

• Zymfentra (infliximab-dyyb) real-world cohort

  This project will see if Zymfentra (infliximab-dyyb) reduces symptoms over one year in adults with Crohn's disease, ulcerative colitis, or indeterminate colitis who are starting or switching to the drug as part of routine care.

  Recruiting at 11 sites University of North Carolina, Chapel Hill · New Haven, Connecticut and 10 other locations · NCT07237516

• Adding Bacillus subtilis to infliximab treatment for Crohn's disease

  This study will test whether taking a daily Bacillus subtilis capsule helps adults with active Crohn's disease who are receiving infliximab.

  Recruiting The Third Xiangya Hospital of Central South University · Changsha, Hunan · NCT07123207

• Optimizing Infliximab Treatment for Inflammatory Bowel Disease

  This study is testing a new way to give infliximab to adults with moderate-to-severe inflammatory bowel disease who haven't improved with steroids, to see if personalized dosing can help them feel better.

  Recruiting Pontificia Universidad Catolica de Chile · Santiago · NCT06758024

• Comparing two drugs and their combination for treating ulcerative colitis

  This study is testing if using a combination of two drugs, infliximab and ustekinumab, can help adults with moderate to severe ulcerative colitis feel better compared to using each drug alone.

  Recruiting Phase 2 Medical University of Lodz · Lodz · NCT06453317

• Infliximab treatment for cognitive dysfunction in depressed individuals with inflammation

  This study is testing if infliximab can help improve thinking and memory in adults with depression who also have signs of inflammation.

  Recruiting Phase 2 Massachusetts General Hospital · Boston, Massachusetts · NCT06136546

• Switching to subcutaneous infliximab for IBD treatment

  This study is testing if switching people with inflammatory bowel disease from an intravenous form of infliximab to a subcutaneous version, given weekly or bi-weekly, can lead to better health results.

  Recruiting at 14 sites Phase 4 Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW · Ghent, Oost-Vlaanderen and 14 other locations · NCT06113913

• Switching between subcutaneous and intravenous infliximab for Crohn's disease

  This study is testing if switching between two forms of infliximab can help people with moderate to severe Crohn's disease achieve better long-term results.

  Recruiting Asan Medical Center · Seoul · NCT06064864

• Treatment with Subcutaneous Infliximab for Crohn's Disease

  This study is testing if a new way of giving infliximab can help people with moderate to severe Crohn's disease feel better without needing steroids.

  Recruiting Phase 3 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam, North Holland · NCT06059989

• Infliximab treatment for Crohn's disease with drug monitoring

  This study is testing if adjusting infliximab treatment based on drug levels helps people with active perianal fistulizing Crohn's disease feel better compared to standard fixed dosing.

  Recruiting Phase 4 Asan Medical Center · Seoul · NCT06051253

• Using infliximab to treat colitis caused by immune checkpoint inhibitors

  This study is testing if adding infliximab to standard steroid treatment can help people with severe colitis or diarrhea caused by cancer immunotherapy feel better faster.

  Recruiting Phase 3 Odense University Hospital · Aalborg and 2 other locations · NCT05947669

• Registry of Infliximab for Children with Crohn's Disease in China

  This study is testing how well Infliximab works and how safe it is for children aged 6 to 17 with moderate to severe Crohn's disease in China.

  Recruiting Phase 4 Taizhou Mabtech Pharmaceutical Co.,Ltd · Beijing · NCT05906576

• Personalized infliximab dosing for Crohn's disease treatment

  This study is testing whether a computer program that customizes infliximab doses based on blood tests can help people with Crohn's disease feel better compared to the usual dosing methods.

  Recruiting at 11 sites Phase 2/3 Children's Hospital Medical Center, Cincinnati · Los Angeles, California and 10 other locations · NCT05660746

• Using infliximab eye drops to prevent glaucoma after corneal transplant surgery

  This study is testing if infliximab eye drops can help prevent glaucoma in patients after they have corneal transplant surgery.

  Recruiting Phase 1/2 Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT05180994

• Combining treatments for children with Crohn's disease

  This study is testing whether combining two treatments for Crohn's disease can help children feel better compared to using just one of the treatments alone.

  Recruiting Phase 4 Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT05043870

• Comparing two treatment approaches for children with ulcerative colitis

  This study is testing whether a new medicine called infliximab works better than traditional steroids for children with moderate to severe ulcerative colitis to help them feel better and heal faster.

  Recruiting Phase 4 Children's Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT04999228

• High dose vitamin D for young patients with inflammatory bowel disease on biologic therapy

  This study is testing if giving high doses of vitamin D to young people with inflammatory bowel disease who are on biologic treatments can improve their bone health and reduce inflammation.

  Recruiting Boston Children's Hospital · Boston, Massachusetts · NCT04331639

• Treatment of acute pancreatitis with infliximab

  This study is testing if a medication called infliximab can help adults with acute pancreatitis feel better and avoid complications.

  Recruiting at 8 sites Phase 2 University of Liverpool · Aberdeen, Aberdeenshire and 13 other locations · NCT03684278

• Infliximab treatment for dolichoectatic vertebrobasilar aneurysms

  This trial will test whether infliximab, a TNFα blocker, can slow aneurysm growth or reduce complications in adults with dolichoectatic vertebrobasilar aneurysms who are not candidates for surgery.

  Recruiting Phase 1/2 University of California, San Francisco · San Francisco, California · NCT02638701

Quick answers

How many clinical trials of Infliximab are recruiting right now?

24, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in United States (8 trials), China (6 trials), United Kingdom (2 trials), South Korea (2 trials), Chile (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 4: 7, Phase 2: 4, Phase 3: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →